Abstract

Background: Human stereoscopic vision is a psychological abstraction emerging from sufficiently grouped monocular signals within a broader unity of simultaneous binocular perception. Incongruent central signals inevitably arise when moving through a visual landscape, due to changing asymmetries of perception, producing signal rivalry. Humans have an evolved capacity to dynamically inhibit incongruous or ambiguous signals in order to maintain a coherent unity of stereoscopic perception, a facility sometimes exploited by optical illusions. Unlike the beneficial mental construct that arises from physiological inhibition, the amblyopic inhibition is permanently unilaterally destructive, has a large field size, is associated with irreversible signal inhibition at the dorsal lateral geniculate nucleus (dLGN), and leads to structural alterations in dLGN that can be demonstrated histologically. Recent reports suggest amblyopic signal inhibition at the dLGN may be selective, preferentially involving the parvocellular system and sparing the koniocellular system. It is not yet known whether physiological inhibition is also pathway specific, but it would be surprising if it were not. The two chromatic opponent systems display differing vulnerabilities in a number of disease states, including optic neuritis and toxic neuropathies, and they followed independent evolutionary paths during phylogenetic development from small primates into apes and humans with larger eyes. Tritan contrast is conducted exclusively by the koniocellular system as far as the striate cortex, so clinical tests of tritan contrast may provide information about koniocellular function in humans. If koniocellular function is not inhibited in amblyopia then tritan discrimination tests may be normal in amblyopic eyes. Objective: In this study the C test for tritan discrimination was employed as a proxy for koniocellular function to discover whether tritan discrimination was affected in proportion with achromatic contrast in the amblyopic eye of 18 amblyopic adults. Method: The tritan contrast and logmar visual acuity results were compared between eyes, using two non parametric statistical tests. Results: The C test scores for tritan discrimination were statistically similar in the normal and amblyopic eyes, but mean logmar acuity scores were significantly different, with a mean of 0.76 in the amblyopic eyes compared to 0.18 in the non-amblyopic eyes. Conclusion: This finding is consistent with preservation of koniocellular signal perception despite parvocellular signal inhibition in amblyopic eyes.

Highlights

  • The koniocellular ganglion cell pathway is functionally and anatomically discrete from the parvocellular pathway in the lateral geniculate nucleus and striate visual cortex of primates [1]

  • The results of the present study show that tritan contrast measured by the C test is better preserved than achromatic contrast measured by logmar acuity

  • The normal C test response in amblyopic eyes is a useful confirmation that the C test design isolates the koniocellular from the parvocellular response

Read more

Summary

Introduction

The koniocellular ganglion cell pathway is functionally and anatomically discrete from the parvocellular pathway in the lateral geniculate nucleus and striate visual cortex of primates [1]. Ross Littlewood: Normal Tritan Discrimination in Amblyopia Suggests Preservation of Koniocellular Function parvocellular rather than koniocellular activation [7]. Recent reports suggest amblyopic signal inhibition at the dLGN may be selective, preferentially involving the parvocellular system and sparing the koniocellular system. It is not yet known whether physiological inhibition is pathway specific, but it would be surprising if it were not. If koniocellular function is not inhibited in amblyopia tritan discrimination tests may be normal in amblyopic eyes. Conclusion: This finding is consistent with preservation of koniocellular signal perception despite parvocellular signal inhibition in amblyopic eyes

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.